Browsing: Minutes

Just three minutes of sprinting may produce a molecular response that looks very different from what happens after 90 minutes of moderate exercise

I’m always a little skeptical of workouts that promise a lot in very little time. If something takes three minutes, part of me assumes it can’t possibly compare to a long run or a full hour at the gym

Rockefeller researchers found that brief sprint workouts trigger powerful blood signals tied to metabolic and cardiovascular health. (CREDIT:

In this week’s Well Enoughnewsletter, I’m attempting to change your life in 10 minutes. It’s a big ask, granted, but I reckon I can have a good crack at it

There’s a big space between being cognitively healthy and having dementia, and it’s a space many of us will enter as we age. After all, just like our bodies, our minds are going to show some wear and tear after decades of use. Keeping up an exercise regimen can help gird our bodies against physical…

Scientists know exercise is an important factor in getting a good night’s sleep, but it’s unclear which types of exercise have the greatest effects

A drastic cut in workout time anchored Dave Asprey’s latest appearance on GOOD NIGHT WITH BEN GLEIB, where the biohacking author detailed how he now trains just 20 minutes a week after years of daily gym sessions failed to change his body. Asprey told host Ben Gleib that six days a week of 90-minute workouts…

Your gym sessions may be locked-in, and your nutrition might be on-point, but if you are failing to hit the hay at a reasonable time, you could be stalling your progress toward getting slimmer. While we are constantly told that adequate sleep is a necessary part of the weight loss journey, getting to bed on…

In our latest 5 minutes with, Dr Jamie L. Weiss, Director, Global Medical Communications and Publications, Rare Disease, Alnylam Pharmaceuticals, talks AI, innovation and why the future of rare disease still depends on human expertise

In our latest 5 minutes with, Dr Jamie L. Weiss, Director, Global Medical Communications and Publications, Rare Disease, Alnylam Pharmaceuticals, talks AI, innovation and why the future of rare disease still depends on human expertise